Search Results - "tyrosine kinase"

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma by Julie Bolcaen, Shankari Nair, Cathryn H. S. Driver, Tebatso M. G. Boshomane, Thomas Ebenhan, Charlot Vandevoorde

Connect to this object online.

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity by Xiaojie Chen, Xiaojie Chen, Xiaojie Chen, Long-Fei Mao, Long-Fei Mao, Long-Fei Mao, Siqi Tian, Xueli Tian, Xueqiong Meng, Mu-Kuo Wang, Weifeng Xu, Yue-Ming Li, Kangdong Liu, Kangdong Liu, Zigang Dong, Zigang Dong

Connect to this object online.

Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells by Yuelong Jiang, Long Liu, Yirong Jiang, Zhifeng Li, Liying Feng, Xinguo Zhuang, Zhijuan Lin, Qiuling Chen, Guoshu Chen, Jixiang He, Guowei Li, Jie Zha, Bing Xu

Connect to this object online.

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients by Anastasia Putri, Ikhwan Rinaldi, Melva Louisa, Soekamto Koesnoe

Connect to this object online.

From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond by Yu Zhou, Zhimeng Yao, Yusheng Lin, Hao Zhang

Connect to this object online.

Effects of a spleen tyrosine kinase inhibitor on progression of the lupus nephritis in mice by Maki Kitai, Noboru Fukuda, Takahiro Ueno, Morito Endo, Takashi Maruyama, Masanori Abe, Kazuyoshi Okada, Masayoshi Soma, Koichi Matsumoto

Connect to this object online.

Activation of Ceramidase and Ceramide Kinase by Vanadate via a Tyrosine Kinase-Mediated Pathway by Eiko Tada, Kaori Toyomura, Hiroyuki Nakamura, Hirotsune Sasaki, Takeshi Saito, Masayuki Kaneko, Yasunobu Okuma, Toshihiko Murayama

Connect to this object online.

Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review by Abrahim Abduelmula, BScN, Asfandyar Mufti, MD, Derrick HY. Chong, BSc, Siddhartha Sood, HBSc, Muskaan Sachdeva, MD, Jensen Yeung, MD

Connect to this object online.

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R by Cornelius Hempel, Frank Totzke, Christoph Schächtele, Abdulkarim Najjar, Wolfgang Sippl, Christoph Ritter, Andreas Hilgeroth

Connect to this object online.

Design and synthesis of a novel photoaffinity probe for labelling EGF receptor tyrosine kinases by You-Guang Zheng, Xiao-Qing Wu, Jun Su, Ping Jiang, Liang Xu, Jian Gao, Bin Cai, Min Ji

Connect to this object online.

Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma by Zhao Y, Zhang J, Tian Y, Xue C, Hu Z, Zhang L

Connect to this object online.

Protein and metabolic profiles of tyrosine kinase inhibitors co-resistant liver cancer cells by Zengbin Wang, Linqing Wu, Yu Zhou, Zhong Chen, Tao Zhang, Hong Wei, Hong Wei, Zhihong Wang, Zhihong Wang

Connect to this object online.

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors by Wu J, Huang H

Connect to this object online.

Molecular profiling of TAM tyrosine kinase receptors and ligands in endometrial carcinoma: An in silico-study by Dilara Fatma Akin, Didem Özkan

Connect to this object online.

Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy by Xiaohan Zhou, Kun Shi, Ying Hao, Chengli Yang, Ruoyu Zha, Cheng Yi, Zhiyong Qian

Connect to this object online.

Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro by Bourn J, Cekanova M

Connect to this object online.

Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy by Josef Jampilek, Katarina Kralova

Connect to this object online.

An Alignment-Independent 3D-QSAR Study of FGFR2 Tyrosine Kinase Inhibitors by Behzad Jafari, Maryam Hamzeh-Mivehroud, Ali Akbar Alizadeh, Mehdi Sharifi, Siavoush Dastmalchi

Connect to this object online.

Hodgkin Lymphoma in a Case of Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors by Smeeta GAJENDRA, Archana SHARMA, Rashi SHARMA, Sunil Kumar GUPTA, Nitin SOOD, Ritesh SACHDEV

Connect to this object online.

Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection by Núria Climent, Montserrat Plana

Connect to this object online.